BioSyent Inc.

BioSyent Inc.verified

RX.V

Price:

$10.7

Market Cap:

$126.17M

BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia. It also offers Cathejell, a product indicated for surface anesthesia and lubrication during various procedures, including cystoscopy, catheterization, endourethral operation, endoscopy, proctoscopy, rectoscopy, and tracheal intubation, as well as used for the symptomatic treatm...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

1996-05-08

Stock Exchange

TSXV

Ticker

RX.V

The PE Ratio as of September 2024 (TTM) for BioSyent Inc. (RX.V) is 17.83

According to BioSyent Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 17.83. This represents a change of 17.64% compared to the average of 15.16 of the last 4 quarters.

BioSyent Inc. (RX.V) Historical PE Ratio (quarterly & annually)

How has RX.V PE Ratio performed in the past?

The mean historical PE Ratio of BioSyent Inc. over the last ten years is 24.77. The current 17.83 PE Ratio has changed 7.10% with respect to the historical average. Over the past ten years (40 quarters), RX.V's PE Ratio was at its highest in in the December 2014 quarter at 55.33. The PE Ratio was at its lowest in in the March 2020 quarter at 8.36.

Quarterly (TTM)
Annual

Average

24.77

Median

23.15

Minimum

15.78

Maximum

52.17

BioSyent Inc. (RX.V) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BioSyent Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 74.74%

Maximum Annual PE Ratio = 52.17

Minimum Annual Increase = -50.56%

Minimum Annual PE Ratio = 15.78

Quarterly (TTM)
Annual
YearPE RatioChange
202316.564.93%
202215.78-5.44%
202116.69-38.40%
202027.0939.14%
201919.47-5.03%
201820.50-23.92%
201726.951.04%
201626.673.40%
201525.79-50.56%
201452.1774.74%

BioSyent Inc. (RX.V) Average PE Ratio

How has RX.V PE Ratio performed in the past?

The current PE Ratio of BioSyent Inc. (RX.V) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

16.34

5-year avg

19.12

10-year avg

24.77

BioSyent Inc. (RX.V) PE Ratio vs. Peers

How is RX.V’s PE Ratio compared to its peers?

BioSyent Inc.’s PE Ratio is greater than Cipher Pharmaceuticals Inc. (11.83), greater than Covalon Technologies Ltd. (-94.97), less than Viemed Healthcare, Inc. (33.86), greater than Hamilton Thorne Ltd. (-431.84), greater than Knight Therapeutics Inc. (-29.26),

Build a custom stock screener for BioSyent Inc. (RX.V) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioSyent Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioSyent Inc. (RX.V) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioSyent Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is BioSyent Inc.'s PE Ratio?

How is the PE Ratio calculated for BioSyent Inc. (RX.V)?

What is the highest PE Ratio for BioSyent Inc. (RX.V)?

What is the 3-year average PE Ratio for BioSyent Inc. (RX.V)?

What is the 5-year average PE Ratio for BioSyent Inc. (RX.V)?

How does the current PE Ratio for BioSyent Inc. (RX.V) compare to its historical average?